Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:46 p.m.

    📋 TRAVERE THERAPEUTICS, INC. (TVTX) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 07:06:02

    Event Type: Financial Results

    Event Details:

    Travere Therapeutics, Inc (TVTX) Reports Q3 2022 Financial Results Travere Therapeutics, Inc (TVTX) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 54167
    • Net Income: (67,032
    • EPS: Not disclosed
    • Cash and equivalents: 179759
      • expected in the second half of 2023

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 9.28K 6.72K $2.56K +38.18%
    Property Equipment Net 10.08K 11.11K $-1.03K -9.24%
    Operating Lease Right Of Use Assets 21.91K 23.20K $-1.29K -5.54%
    Intangible Assets Net 149.92K 148.44K $1.49K +1.00%
    Other Assets 10.81K 11.07K $-262.00 -2.37%
    Current Liabilities Accounts Payable 11.85K 15.14K $-3.30K -21.76%
    Operating Expenses Selling General Administrative 34.97K 99.77K $-64.80K -64.95%
    Other Income Expenses Net Interest Income 988.00 1.06K $-72.00 -6.79%
    Other Income Expenses Net Interest Expense 4.85K 5.49K $-635.00 -11.57%
    Other Income Expenses Net Total Other Income Expense 216.00 688.00 $-472.00 -68.60%
    Net Loss 39.01K 143.00K $-103.99K -72.72%
    Prepaid Expenses and Other Current Assets 6.72K 6.72K $0.00 +0.00%
    Property and Equipment, Net 11.11K 11.11K $0.00 +0.00%
    Intangible Assets, Net 148.44K 148.44K $0.00 +0.00%
    Other Assets 11.07K 11.07K $0.00 +0.00%
    Accounts Payable 15.14K 15.14K $0.00 +0.00%
    Revenue 16.27K 16.27K $0.00 +0.00%
    Operating Lease Liabilities 3.91K 3.91K $0.00 +0.00%
    Selling, General & Administrative 34.97K 99.77K $-64.80K -64.95%
    Interest Income 988.00 1.06K $-72.00 -6.79%
    Interest Expense 4.85K 5.49K $-635.00 -11.57%
    Net Loss 39.01K 143.00K $-103.99K -72.72%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Travere Therapeutics, Inc
    • CIK: 0001438533
    • Ticker Symbol: TVTX
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories